UBS Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

UBS Group’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-49,000	Closed	-$4.86M	–	8589
2019 Q3	$4.86M	Sell	49,000 -31,000	-39%	-$3.08M	﹤0.01%	2407
2019 Q2	$7.93M	Sell	80,000 -90,000	-53%	-$8.59M	﹤0.01%	1947
2019 Q1	$18.7M	Buy	+170,000	New	+$17.8M	0.01%	1181

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

UBS Group's PRAH Position: Q3 2021 in Review

UBS Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 201,839 shares — an estimated $33.3M sold.

UBS Group first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $33.3M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

UBS Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
UBS Group sold 201,839 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $33.3M.
UBS Group first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
UBS Group's PRA Health Sciences, Inc. position peaked at $33.3M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.